Name | N-Tert-Butoxycarbonyl-4-(4-Toluenesulfonyloxymethyl)Piperidine |
---|---|
Synonyms |
tert-butyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)piperidine-1-carboxylate
1-(tert-Butoxycarbonyl)-4-(tosyloxymethyl)piperidine 1-Boc-4-(p-toluenesulfonyloxymethyl)piperidine 1-(tert-Butoxycarbonyl)-4-[(p-toluenesulfonyloxy)methyl]piperidine 1-Boc-4-(tosyloxymethyl)piperidine 1-Piperidinecarboxylic acid, 4-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-, 1,1-dimethylethyl ester tert-Butyl 4-((tosyloxy)methyl)piperidine-1-carboxylate tert-Butyl 4-({[(4-methylphenyl)sulfonyl]-oxy}methyl)piperidine-1-carboxylate N-Boc-4-(4-Toluenesulfonyloxymethyl)piperidine 2-Methyl-2-propanyl 4-({[(4-methylphenyl)sulfonyl]oxy}methyl)-1-piperidinecarboxylate |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 487.8±18.0 °C at 760 mmHg |
Melting Point | 74 °C |
Molecular Formula | C18H27NO5S |
Molecular Weight | 369.476 |
Flash Point | 248.8±21.2 °C |
Exact Mass | 369.160980 |
PSA | 81.29000 |
LogP | 2.90 |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.526 |
Hazard Codes | Xi |
---|---|
HS Code | 2933399090 |
~88% 166815-96-9 |
Literature: Chiesi Farmaceutici S.p.A.; RANCATI, Fabio; Rizzi, Andrea; Linney, Ian; Blackaby, Wesley; Knight, Chris Patent: US2013/34504 A1, 2013 ; Location in patent: Paragraph 0147; 0148; 0149 ; |
~85%
Detail
|
Literature: AstraZeneca AB Patent: US7235559 B1, 2007 ; US 7235559 B1 |
~% 166815-96-9 |
Literature: US5763458 A1, ; US 5763458 A |
~% 166815-96-9 |
Literature: US2004/48881 A1, ; US 20040048881 A1 |
~% 166815-96-9 |
Literature: Journal of Labelled Compounds and Radiopharmaceuticals, , vol. 42, # 13 p. 1289 - 1300 |
Precursor 6 | |
---|---|
DownStream 6 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |